In 2017, Corassist Completed Its First-In-Human (FIH) Stand-Alone Implantation.
The Corolla® TAA Intra-Ventricular Device Was Implanted In A Patient In Israel (RAMBAM). The Patient Showed Subjective Clinical Improvement In LV Diastolic And Systolic Functioning.
